Skip to main content
Clinical Trials/IRCT20191013045092N2
IRCT20191013045092N2
Completed
Phase 3

A comparative study on the therapeutic effect of combined NBUVB (Narrow Band Ultraviolet B) and systemic Simvastatin with NBUVB alone in patients with vitiligo

Shiraz University of Medical Sciences0 sites50 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Shiraz University of Medical Sciences
Enrollment
50
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
5 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Patients who have just started treatment and have not taken medication in the last 6 months

Exclusion Criteria

  • Patients with liver and kidney problems
  • Pregnant or breastfeeding
  • Patients taking simvastatin interfering drug
  • Under 16 years old

Outcomes

Primary Outcomes

Not specified

Similar Trials